Fig. 1From: Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D statusChange in (a) serum phosphate following ferric carboxymaltose infusion in patients with and without IBD; b change in serum phosphate in patients with Crohn’s disease and ulcerative colitis; c association with symptomatic adverse events; d change in serum iFGF-23 and (e) cFGF-23 over the study periodBack to article page